Meibomian Gland Damaging By Glaucoma Treatments

Meibomian Gland Damaging By Glaucoma Treatments Overview Glaucoma is one of the leading causes of blindness worldwide, with a strong link to elevated intraocular pressure (IOP). Effective management of glaucoma primarily involves lowering IOP, usually through the use of topical eye drops. The health of the meibomian glands is crucial for maintaining

Tool for evaluating real world evidence in treatment of retinal disease

Tool for Evaluating RWE in the Treatment of Retinal Disease   Randomized clinical trials have long been held as the gold standard for evidence based medical practices. However, there is a growing consciousness about the value of incorporating data from real world evidence (RWE) into clinical decision making. Information from real world sources such

The Future of Glaucoma Therapy? Microneedles and the Reduction of Intraocular Pressure

The Future of Glaucoma Therapy? Microneedles and the Reduction of Intraocular Pressure Around 75 million people suffer from glaucoma, making it the world’s leading eye disorder that causes irreversible blindness. Vision loss in glaucoma patients is often accompanied by the dysfunction of the retinal ganglion cell axons. This is believed to

Meibomian Gland Damaging By Glaucoma Treatments